Hopp til innhold
NHI.no
Annonse

Hyperaldosteronisme: Prognose

Innhold i artikkelen

Prognosen er god. Etter kirurgisk fjerning av adenom blir mer enn halvparten kvitt sitt høye blodtrykk. Hos de øvrige oppnås vanligvis god kontroll av blodtrykket ved hjelp av medisiner. Men som for andre med forhøyet blodtrykk er det viktig med regelmessig kontroll og oppfølging. 

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Hyperaldosteronisme . Referanselisten for dette dokumentet vises nedenfor

  1. Grytaas MA, Bakke Å, Ueland GÅ, Jørgensen AP. Primær hyperaldosteronisme. Nasjonal veileder i endokrinologi. Versjon 3.1, publisert 18.09.2022. Siden lest 10.01.2024 https
  2. Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101:1889. PubMed
  3. Charoensri S, Bashaw L, Dehmlow C, et al. Evaluation of a best-practice advisory for primary aldosteronism screening. JAMA Intern Med 2024. pmid:38190155 PubMed
  4. Brown JM, Siddiqui M, Calhoun DA, et al. The Unrecognized Prevalence of Primary Aldosteronism A Cross-sectional Study. Ann Intern Med 2020; 173: 10-20. pmid:32449886 PubMed
  5. Cohen DL, Wachtel H, Vaidya A, et al. Primary aldosteronism in chronic kidney disease: Blood pressure control and kidney and cardiovascular outcomes after surgical versus medical management. Hypertension 2023; 80: 2187. pmid:37593884 PubMed
  6. Buffolo F, Pecori A, Reincke M, et al. Long-term follow-up of patients with elevated aldosterone-to-renin ratio but negative confirmatory test: The progression of primary aldosteronism phenotypes. Hypertension 2024; 81: 340-347. pmid:38084587 PubMed
  7. Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004; 89: 1045. PubMed
  8. Stowasser M. Primary Aldosteronism: Rare bird or common cause of secondary hypertension?. Curr Hypertens Rep 2001; 3: 230. PubMed
  9. Hung A, Ahmed S, Gupta A, et al. Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteronism. J Clin Endocrinol Metab 2021; 106: 2423-35. pmid:34008000 PubMed
  10. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709. New England Journal of Medicine
  11. Pitt B, Remme W, Zannad F, Neaton J. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309. New England Journal of Medicine
  12. Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 2017; 5: 689-99. pmid:28576687 PubMed
  13. Chen Y-Y, Lin Y-HH, Huang W-C, et al. Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism. J Endocr Soc 2019; 3: 1110-26. pmid:31086833 PubMed
  14. Monticone S, D'Ascenzo F, Moretti C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2018; 6: 41-50. pmid:29129575 PubMed
  15. Hundemer GL, Agharazii M, Madore F, et al. Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study. Circulation 2024; 149: 124-134. pmid:38031887 PubMed
  16. Stowasser M, Gordon RD, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens. 2003; 21: 2149-57. 14597859
  17. Sechi LA, Novello M, Lapenna R, et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006; 295: 2638-45. PubMed
Annonse
Annonse